APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transfusion Diagnosis for Donor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Transfusion Diagnosis for Donor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

15 January 2026193 pages

Choose your research edition.

Industry ResearchTransfusion Diagnosis for Donor Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Transfusion Diagnosis for Donor Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Transfusion Diagnosis for Donor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transfusion Diagnosis for Donor Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Transfusion Diagnosis for Donor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Transfusion Diagnosis for Donor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Transfusion Diagnosis for Donor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transfusion Diagnosis for Donor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transfusion Diagnosis for Donor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Transfusion Diagnosis for Donor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transfusion Diagnosis for Donor include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH and Diasorin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Transfusion Diagnosis for Donor market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transfusion Diagnosis for Donor and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transfusion Diagnosis for Donor revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Transfusion Diagnosis for Donor market size, projected growth trends, production technologies, key applications, and end-use industries.

Transfusion Diagnosis for Donor Segment by Company

Grifols

F. Hoffmann-La Roche

Abbott

Bio-Rad Laboratories

Werfen

QuidelOrtho Corporation

AliveDx Holdings Finance

BAG Diagnostics GmbH

Diasorin

Prestige Diagnostics

Atlas Medical GmbH

Lorne Laboratories

Transfusion Diagnosis for Donor Segment by Type

Instruments

Kits and Reagents

Transfusion Diagnosis for Donor Segment by Application

Blood Banks

Blood Donation/Transfusion Centers

Others

Transfusion Diagnosis for Donor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transfusion Diagnosis for Donor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transfusion Diagnosis for Donor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transfusion Diagnosis for Donor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Transfusion Diagnosis for Donor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transfusion Diagnosis for Donor industry.

Chapter 3: Detailed analysis of Transfusion Diagnosis for Donor companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transfusion Diagnosis for Donorrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Instruments Table 3. Key Players of Kits and Reagents Table 4. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Blood Banks Table 6. Key Players of Blood Donation/Transfusion Centers Table 7. Key Players of Others Table 8. Global Transfusion Diagnosis for Donor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Transfusion Diagnosis for Donor Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Transfusion Diagnosis for Donor Market Share by Region (2021-2026) Table 11. Global Transfusion Diagnosis for Donor Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Transfusion Diagnosis for Donor Market Share by Region (2027-2032) Table 13. Transfusion Diagnosis for Donor Industry Trends Table 14. Transfusion Diagnosis for Donor Industry Drivers Table 15. Transfusion Diagnosis for Donor Industry Opportunities and Challenges Table 16. Transfusion Diagnosis for Donor Industry Restraints Table 17. Global Transfusion Diagnosis for Donor Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Transfusion Diagnosis for Donor Revenue Market Share by Company (2021-2026) Table 19. Global Transfusion Diagnosis for Donor Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Transfusion Diagnosis for Donor Key Company Head Office and Area Served Table 21. Global Transfusion Diagnosis for Donor Company, Product Type & Application Table 22. Global Transfusion Diagnosis for Donor Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Transfusion Diagnosis for Donor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Transfusion Diagnosis for Donor Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2021-2026) Table 29. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2027-2032) Table 30. Global Transfusion Diagnosis for Donor Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2021-2026) Table 34. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2027-2032) Table 35. Grifols Company Information Table 36. Grifols Business Overview Table 37. Grifols Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Grifols Transfusion Diagnosis for Donor Product Portfolio Table 39. Grifols Recent Development Table 40. F. Hoffmann-La Roche Company Information Table 41. F. Hoffmann-La Roche Business Overview Table 42. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Portfolio Table 44. F. Hoffmann-La Roche Recent Development Table 45. Abbott Company Information Table 46. Abbott Business Overview Table 47. Abbott Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Abbott Transfusion Diagnosis for Donor Product Portfolio Table 49. Abbott Recent Development Table 50. Bio-Rad Laboratories Company Information Table 51. Bio-Rad Laboratories Business Overview Table 52. Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Portfolio Table 54. Bio-Rad Laboratories Recent Development Table 55. Werfen Company Information Table 56. Werfen Business Overview Table 57. Werfen Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Werfen Transfusion Diagnosis for Donor Product Portfolio Table 59. Werfen Recent Development Table 60. QuidelOrtho Corporation Company Information Table 61. QuidelOrtho Corporation Business Overview Table 62. QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Portfolio Table 64. QuidelOrtho Corporation Recent Development Table 65. AliveDx Holdings Finance Company Information Table 66. AliveDx Holdings Finance Business Overview Table 67. AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Portfolio Table 69. AliveDx Holdings Finance Recent Development Table 70. BAG Diagnostics GmbH Company Information Table 71. BAG Diagnostics GmbH Business Overview Table 72. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Portfolio Table 74. BAG Diagnostics GmbH Recent Development Table 75. Diasorin Company Information Table 76. Diasorin Business Overview Table 77. Diasorin Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Diasorin Transfusion Diagnosis for Donor Product Portfolio Table 79. Diasorin Recent Development Table 80. Prestige Diagnostics Company Information Table 81. Prestige Diagnostics Business Overview Table 82. Prestige Diagnostics Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Prestige Diagnostics Transfusion Diagnosis for Donor Product Portfolio Table 84. Prestige Diagnostics Recent Development Table 85. Atlas Medical GmbH Company Information Table 86. Atlas Medical GmbH Business Overview Table 87. Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Atlas Medical GmbH Transfusion Diagnosis for Donor Product Portfolio Table 89. Atlas Medical GmbH Recent Development Table 90. Lorne Laboratories Company Information Table 91. Lorne Laboratories Business Overview Table 92. Lorne Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Lorne Laboratories Transfusion Diagnosis for Donor Product Portfolio Table 94. Lorne Laboratories Recent Development Table 95. North America Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Transfusion Diagnosis for Donor Market Size by Country (2021-2026) Table 101. North America Transfusion Diagnosis for Donor Market Size by Country (2027-2032) Table 102. Europe Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026) Table 108. Europe Transfusion Diagnosis for Donor Market Size by Country (2027-2032) Table 109. China Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & (US$ Million) Table 110. China Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (US$ Million) Table 111. China Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (US$ Million) Table 112. China Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Transfusion Diagnosis for Donor Market Size by Country (2021-2026) Table 119. Asia Transfusion Diagnosis for Donor Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Transfusion Diagnosis for Donor Product Image Figure 2. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Transfusion Diagnosis for Donor Market Share by Type: 2025 VS 2032 Figure 4. Instruments Image Figure 5. Kits and Reagents Image Figure 6. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Transfusion Diagnosis for Donor Market Share by Application: 2025 VS 2032 Figure 8. Blood Banks Image Figure 9. Blood Donation/Transfusion Centers Image Figure 10. Others Image Figure 11. Global Transfusion Diagnosis for Donor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 13. Global Transfusion Diagnosis for Donor Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Transfusion Diagnosis for Donor Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Transfusion Diagnosis for Donor Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Transfusion Diagnosis for Donor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2021-2032) Figure 20. Global Transfusion Diagnosis for Donor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2021-2032) Figure 22. North America Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 23. North America Transfusion Diagnosis for Donor Market Share by Type (2021-2032) Figure 24. North America Transfusion Diagnosis for Donor Market Share by Application (2021-2032) Figure 25. North America Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 26. United States Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 27. Canada Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 29. Europe Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 30. Europe Transfusion Diagnosis for Donor Market Share by Type (2021-2032) Figure 31. Europe Transfusion Diagnosis for Donor Market Share by Application (2021-2032) Figure 32. Europe Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 33. Germany Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 34. France Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 36. Italy Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 37. Russia Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 39. China Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 40. China Transfusion Diagnosis for Donor Market Share by Type (2021-2032) Figure 41. China Transfusion Diagnosis for Donor Market Share by Application (2021-2032) Figure 42. Asia Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 43. Asia Transfusion Diagnosis for Donor Market Share by Type (2021-2032) Figure 44. Asia Transfusion Diagnosis for Donor Market Share by Application (2021-2032) Figure 45. Asia Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 46. Japan Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 50. India Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 51. Australia Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Transfusion Diagnosis for Donor Market Share by Country (2021-2032) Figure 56. Brazil Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 61. UAE Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 63. Chile Transfusion Diagnosis for Donor Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Kits and Reagents
Applications
  • Blood Banks
  • Blood Donation/Transfusion Centers
  • Others
Companies covered
  • Grifols
  • F. Hoffmann-La Roche
  • Abbott
  • Bio-Rad Laboratories
  • Werfen
  • QuidelOrtho Corporation
  • AliveDx Holdings Finance
  • BAG Diagnostics GmbH
  • Diasorin
  • Prestige Diagnostics
  • Atlas Medical GmbH
  • Lorne Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Instruments
  5. 1.2.3 Kits and Reagents
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Transfusion Diagnosis for Donor Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Blood Banks
  9. 1.3.3 Blood Donation/Transfusion Centers
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Transfusion Diagnosis for Donor Growth Trends by Region
  13. 1.5.1 Global Transfusion Diagnosis for Donor Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Transfusion Diagnosis for Donor Market Size by Region (2021-2026)
  15. 1.5.3 Transfusion Diagnosis for Donor Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Transfusion Diagnosis for Donor Market Dynamics
  1. 2.1 Transfusion Diagnosis for Donor Industry Trends
  2. 2.2 Transfusion Diagnosis for Donor Industry Drivers
  3. 2.3 Transfusion Diagnosis for Donor Industry Opportunities and Challenges
  4. 2.4 Transfusion Diagnosis for Donor Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Transfusion Diagnosis for Donor Revenue by Company (2021-2026)
  2. 3.2 Global Transfusion Diagnosis for Donor Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Transfusion Diagnosis for Donor Key Company Head office and Area Served
  4. 3.4 Global Transfusion Diagnosis for Donor Company, Product Type & Application
  5. 3.5 Global Transfusion Diagnosis for Donor Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Transfusion Diagnosis for Donor Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Transfusion Diagnosis for Donor Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Transfusion Diagnosis for Donor Tier 1, Tier 2, and Tier 3
4 Transfusion Diagnosis for Donor Market by Type
  1. 4.1 Global Transfusion Diagnosis for Donor Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Transfusion Diagnosis for Donor Market Size by Type (2021-2032)
  3. 4.3 Global Transfusion Diagnosis for Donor Market Size Share by Type (2021-2032)
5 Transfusion Diagnosis for Donor Market by Application
  1. 5.1 Global Transfusion Diagnosis for Donor Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Transfusion Diagnosis for Donor Market Size by Application (2021-2032)
  3. 5.3 Global Transfusion Diagnosis for Donor Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Grifols
  2. 6.1.1 Grifols Company Information
  3. 6.1.2 Grifols Business Overview
  4. 6.1.3 Grifols Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Grifols Transfusion Diagnosis for Donor Product Portfolio
  6. 6.1.5 Grifols Recent Developments
  7. 6.2 F. Hoffmann-La Roche
  8. 6.2.1 F. Hoffmann-La Roche Company Information
  9. 6.2.2 F. Hoffmann-La Roche Business Overview
  10. 6.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Portfolio
  12. 6.2.5 F. Hoffmann-La Roche Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Abbott Transfusion Diagnosis for Donor Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Bio-Rad Laboratories
  20. 6.4.1 Bio-Rad Laboratories Company Information
  21. 6.4.2 Bio-Rad Laboratories Business Overview
  22. 6.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Recent Developments
  25. 6.5 Werfen
  26. 6.5.1 Werfen Company Information
  27. 6.5.2 Werfen Business Overview
  28. 6.5.3 Werfen Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Werfen Transfusion Diagnosis for Donor Product Portfolio
  30. 6.5.5 Werfen Recent Developments
  31. 6.6 QuidelOrtho Corporation
  32. 6.6.1 QuidelOrtho Corporation Company Information
  33. 6.6.2 QuidelOrtho Corporation Business Overview
  34. 6.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Portfolio
  36. 6.6.5 QuidelOrtho Corporation Recent Developments
  37. 6.7 AliveDx Holdings Finance
  38. 6.7.1 AliveDx Holdings Finance Company Information
  39. 6.7.2 AliveDx Holdings Finance Business Overview
  40. 6.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Portfolio
  42. 6.7.5 AliveDx Holdings Finance Recent Developments
  43. 6.8 BAG Diagnostics GmbH
  44. 6.8.1 BAG Diagnostics GmbH Company Information
  45. 6.8.2 BAG Diagnostics GmbH Business Overview
  46. 6.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Portfolio
  48. 6.8.5 BAG Diagnostics GmbH Recent Developments
  49. 6.9 Diasorin
  50. 6.9.1 Diasorin Company Information
  51. 6.9.2 Diasorin Business Overview
  52. 6.9.3 Diasorin Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Diasorin Transfusion Diagnosis for Donor Product Portfolio
  54. 6.9.5 Diasorin Recent Developments
  55. 6.10 Prestige Diagnostics
  56. 6.10.1 Prestige Diagnostics Company Information
  57. 6.10.2 Prestige Diagnostics Business Overview
  58. 6.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Product Portfolio
  60. 6.10.5 Prestige Diagnostics Recent Developments
  61. 6.11 Atlas Medical GmbH
  62. 6.11.1 Atlas Medical GmbH Company Information
  63. 6.11.2 Atlas Medical GmbH Business Overview
  64. 6.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Product Portfolio
  66. 6.11.5 Atlas Medical GmbH Recent Developments
  67. 6.12 Lorne Laboratories
  68. 6.12.1 Lorne Laboratories Company Information
  69. 6.12.2 Lorne Laboratories Business Overview
  70. 6.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Product Portfolio
  72. 6.12.5 Lorne Laboratories Recent Developments
7 North America
  1. 7.1 North America Transfusion Diagnosis for Donor Market Size (2021-2032)
  2. 7.2 North America Transfusion Diagnosis for Donor Market Size by Type
  3. 7.2.1 North America Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
  4. 7.2.2 North America Transfusion Diagnosis for Donor Market Size by Type (2027-2032)
  5. 7.2.3 North America Transfusion Diagnosis for Donor Market Share by Type (2021-2032)
  6. 7.3 North America Transfusion Diagnosis for Donor Market Size by Application
  7. 7.3.1 North America Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
  8. 7.3.2 North America Transfusion Diagnosis for Donor Market Size by Application (2027-2032)
  9. 7.3.3 North America Transfusion Diagnosis for Donor Market Share by Application (2021-2032)
  10. 7.4 North America Transfusion Diagnosis for Donor Market Size by Country
  11. 7.4.1 North America Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  13. 7.4.3 North America Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
  14. 7.4.4 North America Transfusion Diagnosis for Donor Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Transfusion Diagnosis for Donor Market Size (2021-2032)
  2. 8.2 Europe Transfusion Diagnosis for Donor Market Size by Type
  3. 8.2.1 Europe Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
  4. 8.2.2 Europe Transfusion Diagnosis for Donor Market Size by Type (2027-2032)
  5. 8.2.3 Europe Transfusion Diagnosis for Donor Market Share by Type (2021-2032)
  6. 8.3 Europe Transfusion Diagnosis for Donor Market Size by Application
  7. 8.3.1 Europe Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
  8. 8.3.2 Europe Transfusion Diagnosis for Donor Market Size by Application (2027-2032)
  9. 8.3.3 Europe Transfusion Diagnosis for Donor Market Share by Application (2021-2032)
  10. 8.4 Europe Transfusion Diagnosis for Donor Market Size by Country
  11. 8.4.1 Europe Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  13. 8.4.3 Europe Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
  14. 8.4.4 Europe Transfusion Diagnosis for Donor Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Transfusion Diagnosis for Donor Market Size (2021-2032)
  2. 9.2 China Transfusion Diagnosis for Donor Market Size by Type
  3. 9.2.1 China Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
  4. 9.2.2 China Transfusion Diagnosis for Donor Market Size by Type (2027-2032)
  5. 9.2.3 China Transfusion Diagnosis for Donor Market Share by Type (2021-2032)
  6. 9.3 China Transfusion Diagnosis for Donor Market Size by Application
  7. 9.3.1 China Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
  8. 9.3.2 China Transfusion Diagnosis for Donor Market Size by Application (2027-2032)
  9. 9.3.3 China Transfusion Diagnosis for Donor Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Transfusion Diagnosis for Donor Market Size (2021-2032)
  2. 10.2 Asia Transfusion Diagnosis for Donor Market Size by Type
  3. 10.2.1 Asia Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
  4. 10.2.2 Asia Transfusion Diagnosis for Donor Market Size by Type (2027-2032)
  5. 10.2.3 Asia Transfusion Diagnosis for Donor Market Share by Type (2021-2032)
  6. 10.3 Asia Transfusion Diagnosis for Donor Market Size by Application
  7. 10.3.1 Asia Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
  8. 10.3.2 Asia Transfusion Diagnosis for Donor Market Size by Application (2027-2032)
  9. 10.3.3 Asia Transfusion Diagnosis for Donor Market Share by Application (2021-2032)
  10. 10.4 Asia Transfusion Diagnosis for Donor Market Size by Country
  11. 10.4.1 Asia Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  13. 10.4.3 Asia Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
  14. 10.4.4 Asia Transfusion Diagnosis for Donor Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Transfusion Diagnosis for Donor Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst